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palavras-chave 
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dispositivos 
resumo 
 
 
Spesis é uma doença que resulta numa infeção geral do organismo, causada 
por agentes patogénicos. É uma enfermidade com uma elevada taxa de 
mortalidade, a maior parte das vezes resultante de diagnóstico tardio. Isto ocorre 
porque a sua deteção muito é, em geral, muito demorada em comparação com 
a velocidade de evolução da doença. Por outro lado, o processo de deteção 
implica que sejam feitas várias análises ao sangue do paciente, as quais são 
feitas por departamentos distintos e a diferentes taxas de execução. Até todas 
as análises serem concluídas para posteriormente serem visualizadas pelos 
médicos, a doença continua a progredir. A solução para este problema, passa 
por métodos de diagnóstico mais eficazes e atempados, bem como a troca de 
informação sobre o estado do paciente em tempo real, ao longo de todo o 
processo. 
 
Nesta dissertação vamos apresentar uma plataforma web que é responsável por 
fornecer toda a informação atualizada aos vários utilizadores envolvidos, os 
quais podem obter em tempo real a informação associada à análise de um 
paciente e ao seu estado atual. O fornecimento contínuo de informação garante 
que os vários utilizadores tomem decisões mais informadas em relação ao 
tratamento do paciente, permitindo uma taxa de eficiência superior à atual. 
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abstract 
 
 
Spesis is a disease that generally results from an infection of the organism, 
caused by pathogens. It is a disease with a high mortality rate, most often 
resulting from a late diagnosis. This happens because his detection is much 
slower in contrast to it’s rate of evolution. On the other hand, the detection 
process requires several analyzes to be made from the patient's blood, which 
are done by different departments at different implementation rates. Until all 
analyzes are completed, for a later analysis by the doctors, the disease continues 
to progress. The solution to this problem involves methods more effective and 
timely diagnosis, and also the exchange of information about the patient's 
condition in real time, throughout all the process. 
In this thesis we present a web platform that is responsible for providing all the 
updated information to the various users involved in the process, which can get 
real-time information associated with the analysis of a patient and their current 
state. The continuous supply of information ensures that all the users can make 
more informed decisions regarding the best treatment for patient, allowing a 
higher efficiency rate than the current one. 
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Chapter 1 
 Introduction 
This thesis presents the main ideas and basic stages of design and 
development of a web platform called HemoSpec Platform. This software will 
be developed by BMD Software, an SME located in Aveiro, under the 
European Union project HemoSpec. 
HemoSpec will feature a medical web platform containing all the relevant 
information related with patients and allowing users to take right decision, 
at the right time.  This platform’s main aim is allowing a fast and reliable 
diagnosis of the sepsis disease, leading to an early and more effective 
treatment, consequently improving the current rate of success. It will include 
a multiplex photonic surrogate process that simultaneously analyses 
biomarker in the plasma and probes the biophotonic fingerprint of blood cells 
[1]. 
HemoSpec’s web platform will be the front end for each player involved in 
the patient’s treatment workflow. This platform will allow managing 
patients, exams and diagnostics in a unique console. For each diagnostic 
requested, the application backoffice will trigger exams and laboratory 
studies. The resulting data is then integrated and submitted by the developed 
classification models that will lead to the final diagnostic. Each player will 
have instant access to the patient’s data and workflow. This improves the 
user interaction with the patient’s process, granting the ability to take all 
necessary actions through a browser (Chrome, Mozilla Firefox, etc.), that 
allows managing the patient’s treatment workflow. Users involved in the 
patient’s workflow are notified when the patient information changes. This 
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communication mechanism ensures a more reliable and immediate 
information exchange process between different users. 
To correctly understand all system’s workflow and all kinds of 
functionalities that the platform supports, as well as if it fulfills all 
requirements, a detailed list of the proposed requirements, the mockups 
obtained from requirements and the final user interface will be presented. 
 
1.1. Motivation 
Currently, there is still a lack of information about Sepsis disease around 
the world [1]. Therefore, the treatment priority is low while the disease 
evolution is increasing dramatically, as well as the growing mortality rate of 
the disease. In addition, a clear diagnosis can be lengthy and complicated, 
due to highly variable symptoms and non-specific criteria, causing the disease 
to be diagnosed and treated too late (Figure 1). 
Beyond the mentioned restrictions, other big hindrances are the 
procedures needed to confirm the diagnosis. Initially, it is necessary to collect 
four patient’s blood samples which will be distributed within the different 
laboratories to perform specific analysis. After this, each laboratory writes a 
report (on paper format) and sends it to the technician responsible for 
gathering and forwarding them to the physician, who will then analysis and 
take a decision according to the patient’s condition. However, during this 
process failures can occur, since liability and data security cannot be 
guaranteed during the analysis process. A critical situation is the extensive 
waiting time. Physicians have to wait by all reports before making a decision, 
which can affect its accuracy considering that some reports might already be 
outdated. 
This time consuming process affects the disease’s development, causing 
the treatment to be applied too late, reducing the rate of success. 
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Figure 1 – Actual sepsis treatment 
 
Patients are the most harmed by this long workflow, since they depend 
exclusively on the diagnostic speed. Even though they don’t interact directly 
with the system, they are considered to be its central element.  
Currently, “the sepsis mortality range is from 7% within the less severe 
cases to almost 50% in case of septic shock” [1]. This value clearly implies the 
necessity of an early diagnosis and severe treatment. In that sense, the main 
goal of the HemoSpec system is to drastically reduce the mortality range, 
enhancing the treatment’s success. 
Summarizing, we can conclude that the current sepsis diagnosis process 
is slow and complex, implying several steps from different actors, which 
affects the patient’s treatment. While occurs the process of collecting the 
blood, writing the reports and taking them to the respective physician, many 
complications may arise such as loosing or mixing documents that retarding 
the diagnosis. The current used methodology has not proven to be efficient 
and reliable, seriously causing damages to the involved patients and 
contributing to the increase of the sepsis’ mortality rate. 
To address this problem the HemoSpec system is being developed, 
consisting of two main components: HemoSpec Platform and HemoSpec 
Device. 
The HemoSpec Platform allows the physician to create and start a 
patient’s workflow, where we can see all information about on-going 
processes. After starting the workflow, the platform notifies technicians that 
a new case is ready to be analyzed. Then, a technician places just one patient’s 
blood sample (1-2ml) in the HemoSpec device, avoiding the distribution of 
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several samples like in the actual process, which is also less harmful to the 
patient. To achieve this, HemoSpec Device involves “the development of three 
modules for rapid detection of four biomarkers to advance the diagnosis and 
management of sepsis: automated micro-fluidic sample handling, 
simultaneous multiplex fluorescence biomarker sensing and detailed Raman 
spectroscopic leukocyte characterization” [1]. After, the device alerts if the 
sample was well inserted and the technician can start the analysis process, 
having full control of it, which means he can interact instantaneously by 
starting, stopping or resetting it. 
When this workflow part is finished, the device will then present the 
results, which will be immediately available to all the actors involved in the 
patient’s treatment. When the technician validates the results, the HemoSpec 
Platform stores them and performs a background data-mining process that 
allows concluding the disease classification based on real facts. According to 
this classification, new information is added to the patient’s profile. 
HemoSpec centralizes all information about patient’s disease treatment and 
shows this data on HemoSpec Platform. Finally, physicians can visualize the 
final results, in real time, ensuring an anticipated patient’s diagnosis and 
suitable treatment (Figure 2). 
Therefore, our solution intends to reduce the procedure time, the risk of 
errors within the process of exchanging data and guarantee that the patient 
receives on time, the proper treatment according to his needs. This will also 
lead to a reduction of the mortality rate and related treatment costs. 
 
Figure 2 – Integrate HemoSpec project in sepsis treatment 
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1.2. Goals 
The aim of this thesis focuses mainly on the following points: the first goal 
is the development of a web platform to incorporate in the HemoSpec project. 
As a second objective it has the intention to create a set of web services that 
permits external clinical and diagnostic modules to communicate 
automatically with this system. The last objective is to develop a 
communication protocol that allows to synchronize data and actions to be 
performed between HemoSpec Platform and the HemoSpec Device, ensuring 
updated data. 
From a top down approach and to achieve the goals, it will be necessary 
to go through the following steps: 
 Project requirements analysis; 
 Mockups; 
 System architecture design; 
 Develop a communication protocol; 
 Understand user interface design patterns; 
 Client/Server development (HTML5, CSS3, Javascript, Web 
Services …). 
 
1.3. Thesis outline 
The remaining chapters of this thesis are organized according to the 
following: 
Chapter 2 lists a set of system’s requirements, like user requirements 
that guided the development of our solution, and detects limitations and 
issues that needs to be covered. We present a list of use cases and respective 
diagrams that shows necessary actions supported by the platform. Also, we 
present an activity diagram that describes a basic workflow of the solution. 
Finally, we show the mockups obtained after analyzing all requirements. 
Chapter 3 presents HemoSpec architecture. In this section we start by 
presenting the overall architecture of the solution. After, we describe specific 
information related with the client-side and server-side of the application. In 
the server side section, we describe the communication protocol that ensures 
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all data exchanges, and the actions that occurs inside of the HemoSpec 
project. 
Chapter 4 presents the overall implementation of the designed solution. 
Firstly, we present the system description. Secondly, we describe the 
implementation of the communication protocol and finally we show and 
explain the HemoSpec Platform’s user interface.  
Chapter 5 presents an analysis of the user testing plan to validate the 
usability and the proper functioning. Results are also shown. 
Chapter 6 presents some conclusions about the work done, as well as 
future work that can be done in order to improve the developed solution. 
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Chapter 2 
 Requirements analysis 
In this chapter we will describe the several requirements of the solution, 
which guarantee the development of an innovative web platform that we aim 
to achieve. The platform allows to resolve the current problems of the sepsis 
treatment process and provides new advantages to the users. Finally, we will 
also show and describe the mockups of the platform. 
 
2.1. Features and system boundaries 
As general design principles we can already identify the following system 
characteristics and features: 
 Communication protocol (security, privacy and standardization); 
 Authentication system; 
 Secure data exchange (web-services exchange data over SSL1); 
 Event-driven (asynchronous communication); 
 Scalability (capacity to serve different number of devices in different 
time); 
 Resilient (capacity to recover of fails instantaneously); 
 Responsive (automatically synchronize page content when occur 
modifications in the system); 
 Collect information in a centralized knowledge database; 
 
                                                        
1 SSL – Secure sockets layer 
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2.2. Stakeholders 
The solution involves several users during the process workflow. Users 
interact with the system in specific phases of the workflow. Each user 
assumes different roles in the system according each specific step.  
All the responsibilities of each stakeholder involved in this project were 
established during the project kick off meeting. These roles are detailed on 
Table 1. 
Table 1 – List of Stakeholders 
Stakeholder Description Responsibilities 
Physician 
User that initiates and 
finishes the patient 
workflow in the 
HemoSpec platform, 
with direct interaction 
with patients. 
Starts a patient’s process, 
enabling the technician to do 
a blood analysis workflow. 
Afterwards, he is notified 
about the generated results, 
analyses patient’s status and 
defines the right treatment. 
Technician 
Member that forwards 
the patient’s workflow 
after receiving an 
order from the 
physician. He also 
manages the patient’s 
blood analysis 
workflow. 
Ensures that the correct 
blood sample is properly 
inserted in the machine, and 
verifies if all is correct to 
start the analysis process. 
Then, he has to validate the 
results, and allow the 
workflow to continue. 
HemoSpec 
System 
Catches the checked 
results and compare 
them with specific 
values according to 
defined criteria. 
Concludes the 
adequate treatment 
and notifies the 
physician. 
After receiving the validation 
from the technician, it 
initiates the last workflow 
step. Processes the patient’s 
data and, based in specific 
values, classifies the 
patient’s disease severity.  
Finally, according to specific 
values, it suggests the 
adequate treatment. 
 Patient 
Main target of the 
process, but doesn´t 
interact with the 
system. 
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Administrator 
User with maximum 
privileges in the 
system. He can 
manage and control all 
aspects of the 
platform. 
Manages user permissions in 
the system: change roles or 
edit users’ data. 
Can also use all permissions 
(physician, technician …) to 
manage the system and 
guarantee that all the data 
are accurate and ensure the 
system works correctly. 
 
 
2.3. Stakeholders requirements 
In this section we will describe the needs that every user has with the 
system. Some of the needs are specific of each stakeholder, but also exist 
needs that are common between stakeholders. On the one hand, physician 
and technician have in common the account and access to a private workspace 
requirement, on the other hand, they have specific requirements applied in 
your specific context. While physician has requirements according to the 
creation, starting and management of the patient’s workflow, the technician 
has requirements related with the blood analysis workflow. The HemoSpec 
system has specific requirements according to the application in terms of 
performance, communication protocol, etc. Finally, the administrator has 
requirements related with management of users and system. 
During the project’s kick off meeting, we started analyzing the general 
system requirements and also the specific requirements to each stakeholder 
(Table 2).  
Table 2 – List of stakeholder’s requirements 
 Requirement Description 
Physician 
Access to a 
private workspace 
See all ongoing patients’ workflows. 
Create and start 
patient’s workflow 
Physician creates the patient’s 
process in the system, workflow 
that has a sequence of steps and 
starts the workflow. 
Manage patient’s 
workflow 
Physician can consult the patient’s 
information in the workflow and 
submit the right treatment. 
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See workflow’s 
state  
Physician can consult the state of a 
processing workflow. 
Account Full control of the account. 
Technician 
Access to a 
private workspace 
See all running blood samples 
workflows. 
Start blood 
sample workflow  
After receiving a notification from a 
physician, technician collects a 
blood sample and inserts it in the 
device, receiving a validation from 
the HemoSpec device. 
Manage blood 
samples workflow 
Technician can see and manage 
each process in execution and, 
when a process is concluded, he 
verifies if the results are correct. 
Account Full control of the account. 
HemoSpec 
System 
Authentication  
The system has to limit authorized 
user access and ensure the 
attribution of correct permissions. 
Performance 
System guarantees an efficient and 
fast process, avoiding any delays in 
the system.  
Notification 
mechanism  
The system has a notification 
mechanism to inform the users that 
a specific activity has started. 
Communication 
protocol 
It supports a communication 
protocol and allows the technician 
to control the blood sample 
workflow through the HemoSpec 
platform. 
Support 
The system should support 
different web browsers. 
Administrator 
Manage users 
Administrator can add, remove and 
control each user’s access and 
permissions.  
Manage system 
Administrator has access to all 
system’s components. He can view 
or edit all data, in order to avoid 
incorrect information on the 
workflow. This ensures that 
problems or conflicts on the system 
don’t occur. 
 
2.4. Functional requirements 
The functional requirements were defined and detailed in 4 different 
areas: 
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 System requirements: overall system features; 
 Patient workflow management: overall patient workflow features; 
 HemoSpec process: requirements associated with HemoSpec device 
and system; 
 Platform management: requirements associated with the platform 
administration. 
The first area, system requirements, defines functional requirements 
associated with the authentication process, the management of user accounts, 
patients, and consultations: 
 Support different user profiles, such as physician, technician and 
administrator; 
 Private account management: users need to be registered and have 
the account validated to use the system; 
 Users can view and manage all patient’s process; 
 Users should be able to search for several consultations in the 
platform; 
 Users should be able to search for patients; 
 Technicians should be able to interact with device. 
Additionally, users should be able to edit their account information, 
such as name, password and address. 
Now, we will describe the management area of patients’ workflow, which 
is the main requirement of the system. This allows users to have total control 
about the patient workflow: 
 The system will be used to create and start patient’s workflows and 
to display the current status of the patient’s workflow; 
 User should be able to control the actual patient’s workflow; 
 User should be able to analyze patient’s results; 
 User should be able to consult the patient’s history. 
On the other way, HemoSpec process is responsible for controlling all the 
blood analysis process. This is the most important phase of the patient’s 
workflow, since all the decisions taken by the physician and technician 
depend of analysis results’: 
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 Technicians should be able to control the analysis process (start, 
stop, reset); 
 Users should be able to consult the analysis process status; 
 HemoSpec system collects results from several modules and analyze 
this results; 
 HemoSpec system classify results and conclude the patient’s state; 
 Technicians should be able to validate the results. 
The last point, platform management represents several requirements 
that are fundamental to ensure that all work correctly. An administrator 
should be able to configure data associated with specifics organizations, 
patients, etc. Following, there are requirements related with platform 
management: 
 Administrator should be able to manage several organizations; 
 Administrator should be able to add, edit and remove roles 
associated to several organizations; 
 Administrator should be able to manage users; 
 Administrator should be able to add, edit and remove patients; 
 Administrator should be able to manage devices associated with 
each organization. 
 
2.5. Non-functional requirements 
In addition of all functional requirements listed in the previous section, 
there are other issues and restrictions that our solution needs to overcome.  
Below, we will describe the main non-functional requirements of our system 
that are responsible to cover these issues and restrictions. 
 
2.5.1. Usability 
Usability and user-friendly interfaces should be an important 
requirement for a complete platform.  These characteristics ensure a fast and 
easy perception of the content presents in the web page. In this way, users 
instantaneously observe the most important items and can be easily guided 
by the system. The user interface must keep the content as concise as 
possible, allowing user that first see the most relevant and recent information 
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and after the less relevant information. The interface should present the 
information by sections allowing distributing the information by theme or 
relevance. To facilitate the web page legibility also is important an adequate 
spacing between sections of information or even characters, words, lines, etc. 
It is also important to use visual strategies like photos, charts and graphs 
that can easily express rich information [2]. 
So, HemoSpec will be a web application that follows the characteristics 
mentioned before and will be based on an intuitive, simple, user-friendly and 
direct visual interface. It intends to be easy to use, with only a few steps 
required to reach specific information [3]. 
A documented API, a tutorial and a few examples of the use of this API 
should be provided. HemoSpec should be in available in English, to reach a 
larger range of users. 
 
2.5.2. Resilient 
Actual web platforms should always be available and able to handle 
several users at the same time, over the same workflow, without failures or, 
in extreme cases, ensuring spontaneous system’s recovering. It also needs to 
ensure that when a user executes an action, this action is executed.  If the 
system breaks in the middle of an action, the system must ensure that user 
data are saved, and are available for later submission [4]. 
 
2.5.3. Performance 
The visualization of the platform is affected in great deal by performance 
issues, such as, the loading of data and the speed of rendering the browser 
window. All the tasks involved in the platform should be performed the 
quickest as possible in order to avoid long delays that compromise the entire 
application usability. However, performing these tasks using standard web 
developing techniques, such as HTML, CSS and JavaScript, can be more 
difficult than it looks like. Thus, the design and optimization of the rendering 
and document parsing algorithms is crucial to maintain the desired 
performance. 
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2.5.4. Supportability 
The system supportability is another important requirement, allowing 
the access to the developed solution in almost all modern browsers (Chrome, 
Firefox, Opera), ensuring that the several users can use different browsers 
according to their preferences. Also, it is possible to use this solution in 
different operating systems according to the preferences of each user. 
The platform must also guarantee that version’s updates made to the 
system won’t affect its normal performance. 
 
2.6. Architectural requirements 
After we have analyzed and described functional, non-functional and 
stakeholders’ requirements, we need to have in consideration the 
architectural requirements. The architectural requirements are important 
because they ensure the correct working of the solution. 
To comply with all requirements we have to define an appropriate 
architecture for the system that guarantying the working of the solution. To 
define these requirements we need to consider the software, hardware and 
communication interfaces, as well as the type of required communications. 
 
2.6.1.  Software interfaces 
Software interfaces are developed under a web server, which is 
responsible for receiving a request, process this request and return the 
answer. 
So, to ensure a correct communication between the client-side and the 
server-side of the solution, it is fundamental that we have appropriated 
interfaces that manage all requests, deal with possible errors and return the 
correct answer to the client. 
Summarizing, the web server ensures the system’s communications and 
keeps data synchronized.  
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2.6.2. Hardware interfaces 
As described in the last section, to support software interfaces we need a 
web server, but to maintain a web server running we need a specific 
hardware, in concrete a server that support the respective web server as also 
the HemoSpec database.  
 
2.6.3. Communication interfaces 
After we have considered the software and hardware interfaces, we also 
need to take in attention the communication interfaces. Since the 
communication interfaces are the base to ensure the correct communication 
between the client-side and the server-side of the HemoSpec solution. So, the 
system requires a protocol to ensure the communication between all 
components involved in the system. The respective protocol is based in a 
standard API that respects a specific communication’s structure. This API 
will use the RESTful web services, to ensure a correct and easy 
communication.  
 
2.6.4. System Communication type 
Considering that the HemoSpec system has several actions running in 
real-time and the system involves more than a unique user, it is necessary to 
apply asynchronous communication in order to allow processing multiple 
messages in parallel, without blocking. 
This type of communication avoids queuing data, guaranteeing that more 
data are transferred at the same period of time and also it ensures that the 
communication is faster compared to the applications that use synchronous 
communications. Therefore, the most important characteristic of this 
communication type is assuring non-blocking parallel messages, permitting 
instantaneous data exchanges. 
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2.7. User interface requirements 
User interface design has the goal of making user’s interaction as efficient 
and simple as possible, ensuring that the user can perform an action with the 
minimum number of clicks. It is important that the interface will be simple 
and agreeable, so that, the user instantaneously visualizes the relevant 
information and does not lose time searching the information in the middle of 
the context. 
To guarantee that a user-friendly interface it is necessary to follow a list 
of specific requirements:  
 User interface is adapted to user experience and knowledge; 
 User interface is adequate for each task; 
 Providing control to the user about the interface; 
 User interface is easy to use and quick to learn; 
 The interface should be redundant, so that ensure an easy way to doing 
a specific action. 
Summarizing, the Platform’s design will be taken into account, so that, 
the user interface must be attractive and clear. It should allow users to easily 
interact with the system and also should be provided the necessary tutorials. 
 
2.7.1. Layout and Navigation Requirements 
 Dashboard/workspace where users can find their studies; 
 Dashboard where users can manage the devices; 
 A screen to create and manage the workflows; 
 A screen to manage personal data; 
 An administration screen to manage, create or delete organizations, 
users, patients, devices and control added information; 
 A screen with FAQ and tutorials about the platform. 
 
2.7.2. Consistency 
Consistency is increasingly an important requirement in the websites 
constructions, because nowadays we can access to a specific website from 
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several devices (tablets, smartphone, smartTV, LCD, etc.). So, it is important 
to keep a consistent website to ensure that the users do not notice a difference 
using different screen layout and do not have to learn new tricks to navigate 
and manage the website due the size. The user should feel comfortable to use 
the website, so he continues to use it.  
On the other hand, interface should have a uniformed look. The 
uniformed look should follow a set of different types of consistency, such as: 
 graphic consistency; 
 icon and button consistency; 
 color consistency; 
 typographic consistency. 
 
2.8. Interactions requirements 
In this section we will present and explain all relations that occur between 
system’s components during the process, where we detail in specific each 
relation and finally we will present all interactions that occur during all 
workflows and that involve all components. 
 
2.8.1. Relation between system’s components 
Figure 3 is a scheme that describes an overall HemoSpec architecture and 
details the several architectural components that comprises the system. In 
general, the system is divided into three different assets: 1) the HemoSpec 
platform, which is the most important component; 2) the HemoSpec device; 
and 3) the Client-side interface that is a sub-component of the HemoSpec 
platform, although we consider here as an individual component. 
We will start describing the relations of the Client-side interface. The 
interface is fundamental to allow the user interacts with the platform, the 
interface allows that different types of users interact directly with the system 
and each user type has appropriated access rights. Both physicians and 
technicians can work in several cases, where physicians manage more in 
general the patient’s workflow, whereas technicians manage more in 
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particular the blood analysis workflow. During the patient’s workflow which 
is part the blood analysis process, every change that occurs is instantaneously 
synchronized in the platform. This allows that each user having instant 
access to the updated information. 
HemoSpec device is the component responsible for control blood analysis 
process. The device is formed by 4 different modules, each module is 
responsible for doing a specific part of the blood analysis process. After 
physician starts a patient workflow through the Client-side interface, 
instantaneously the technician is advertised to execute the blood analysis. So 
the technician starts the analysis also through the Client-Side interface and 
after the analysis is terminated, he validates the data or restarts the process 
in the case of any anomaly in the process. If the data is validated, the platform 
stores this data to accelerate the patient’s workflow and process the final step 
of the process. 
Finally, we will describe the relation of the HemoSpec platform. This 
component is the main part of all process, because coordinates all relations 
between the Client-side interface and the HemoSpec device. And manage, 
control and processes all system’s workflows. 
Summarizing, HemoSpec platform coordinates all the workflow, 
synchronizing all performed tasks and manage all the data-mining process to 
conclude the patient status. After obtained the actual patient status presents 
this information to the final users. 
 
Figure 3 – Architecture of the HemoSpec Platform components 
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2.8.2. Interactions between components 
In this section, we present all the interactions between different 
components, divided into three phases. 
Figure 4 represents the first phase of the patient’s treatment workflow. 
Basically, this is initiated by the first interaction between the patient and the 
physician, while in parallel is recovered the patient’ blood that will be used in 
the analysis process. In the final of the patient-physician interaction, 
physician creates and starts the patient’ workflow. After, this information is 
submitted to the system, the system will automatically notify the technician 
that a new process has initiated. The technician receives information about 
the process, catches the respective blood sample and introduces it into the 
device. After he inserts the sample into the HemoSpec device, the device 
notifies the technician if all is well with the placement of the sample or if not.  
 
Figure 4 – System’s architecture before the analysis workflow 
 
In the second phase the technician starts the analysis process, through 
the web interface. Since started the analysis process, this action will be 
controlled by the HemoSpec platform.  
The analysis process requires only a minimal amount of patient’s blood. 
During the analysis, the HemoSpec device will perform a hemogram count 
and a detailed Raman spectroscopic characterization of the leukocytes. 
During this process, users can verify the status of each analysis module 
in real-time and when each module returns a status value “Completed”. After 
the device concludes the parallel analysis process and the software controller 
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(platform) gathers the results of each specific module, data are stored in the 
platform database. 
Finally, the results are delivered to the technician, who validates them, 
or in case of any anomaly, restarts the process (Figure 5). 
 
 
Figure 5 – System’s architecture during the analysis workflow 
 
The third and final step of the patient’s treatment workflow is detailed on 
Figure 6. After the results validation, the system starts a data mining 
process, where it firstly occurs the data fusion from the several modules. The 
next step is to make a classification models based in standard values that 
classify the severity of patient status and notify the physician about the 
patient status. 
The information provided to the physician and justified according with 
the referred values ensures the liability of the classification process. 
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Figure 6 - System’s architecture after the analysis workflow 
 
2.9. Application requirements 
To finalize the requirements analysis of all the solution, in this section we 
will show and explain all the use cases related with the solution and that 
express all possible sequences of interactions between system and users. We 
will also show use-case diagrams that present all available functionalities of 
the system and we will present an activity diagram that explains the general 
workflow [5]. 
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2.9.1. Use cases 
In this sub-section, we will present all the existent use cases that 
represent all the interactions between actors and the system [6]. We divided 
the several use cases by different packages, where each package describes use 
cases related with specific sections of the solution. This way, the solution was 
divided in five packages (Table 3) 
Table 3 – List of use cases 
Package Use case Use Case Description 
Authentication 
Login 
The system verifies 
registration and permissions. 
Logout 
User terminates his session 
in the system. 
Recover password 
The user forgets his 
password and asks for a new 
one. 
User 
Invite 
Administrator sends an 
invite. 
Register Invite 
Member receives an invite 
and finishes the registry. 
Change role 
Administrator manages the 
users’ access and 
permissions. 
Search 
 
Administrator searches for a 
specific member. 
 
Edit User can edit specific data. 
Patient 
workflow 
Create 
Physician creates a patient 
process in the system. 
Start 
Physician begins the 
patient’s workflow. 
Search 
User searches for a specific 
patient’s workflow. 
View Status 
User observes the patient’s 
workflow status. 
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View results 
User analyses the patient’s 
workflow result. 
History 
Physician and Technician 
can consult and analyze past 
patient’s workflows. 
HemoSpec 
device 
Clean 
Technician prepares the 
device to start another blood 
analysis workflow.  
Start 
Technician initiates the 
analysis process. 
Stop 
Technician stops the analysis 
process.  
Status 
Technician consults the 
analysis status. 
Collect results 
HemoSpec joins results from 
all modules. 
View results Shows the analysis report. 
Validate results 
Technician analyses and 
indicates if the results are 
accurate. 
Restart 
Technician can reinitiate the 
analysis process. 
HemoSpec 
system 
Data fusion 
System joins all patients’ 
data. 
Data storage 
System storages the patients’ 
data in the database. 
Classification 
According to the analyzed 
data, the patient’s condition 
is concluded. This 
information provided enables 
a better sub classification of 
the patient groups and 
improves the diagnostic 
accuracy. 
Treatment 
System notifies that the 
patient’s workflow is ready. 
Notification 
Create 
System updates the workflow 
status and creates a 
notification.  
Add 
After the notification, the 
system notifies the next user 
involved. 
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View 
User receives a notification 
and can view its content. 
List 
System shows a list of all 
pending notifications. 
 
2.9.2. Use- case diagrams 
In this subsection we will describe in detail the set of packages referred 
in the last sub-section and we will also specify the respective use cases [7]. 
So, we will begin with the authentication package that is presented in the 
Figure 7. The figure represents a common package for all users. Like we 
referred, the “Authentication” package includes use cases associated with 
system access. Follow, we will describe the list of use cases: 
 Login – represents the interaction between the user and the system, 
where the system verifies registration and permissions of the user to 
access; 
 Logout – it is the inverse case of login use case, where the system ends 
the session of the user; 
 Recover password – This use case represents a specific case, when the 
user forgets his password and asks for a new one to access again. 
Login
Logout
Recover password
User
 
Figure 7 - Use case diagram for the Authentication package 
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Bellow, we will present the User package that involves two different user 
types. On the one hand, we have the system administrator who has access to 
all use cases, on the other hand, we have in particular the physician and the 
technician which only have access to the Register invite and Edit use case. 
We will describe all the use cases of the User package showed in the Figure 
8: 
 Invite – when the administrator wants to add a new user to the system, 
he inserts user data in the system and automatically the system will 
be sent an invite to him; 
 Register invite – a member receives an invite from the system and 
finishes the registry process; 
 Change role – administrator can edit the user’s access and permissions; 
 Search – use case that represents the action of the administrator 
searches for a specific member; 
 Edit – Each user can edit your specific data. 
 
Change role
Search
Edit
Administrator
User
Invite
Register invite
 
Figure 8 - Use case diagram for the User package 
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Follow, we will speak about the Patient package that includes all uses 
cases that directly interacts with the patient’s workflow during the processing 
time. The stakeholders involved in this package are the physicians and 
technicians. Now we will describe the several use cases that belong to the 
Patient package (Figure 9). 
 Create – physician creates a new patient process; 
 Start – physician begins the patient’s workflow; 
 Search – user searches for a specific patient’s workflow; 
 View Status – user observes the patient’s workflow status; 
 View results – user analyses the patient’s workflow result; 
 History – Both, the physician and the technician can consult and 
analyses past patient’s workflows. 
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Create
Start
Search
View status
View results
History
Physician
Thecnician
 
Figure 9 - Use case diagram for the Patient Package 
 
Now we will describe the HemoSpec device package that represents all 
use cases that have a direct relation with the device.  Two different users 
interact with the device and they have specific functions. The main user in 
this package is the technician who has permission to interact with major of 
the use cases, whereas the HemoSpec system can only interact with the View 
results and collect results use cases. After we can see the list of all these 
specifics use cases: 
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 Clean – technician cleans the device and allows preparing the device 
to another blood analysis process; 
 Start - technician begins the analysis process;  
 Stop – technician can break the analysis process; 
 Status – technician can visualize the analysis status; 
 Collect results – After terminates the blood analysis process, the 
HemoSpec system joins results from all modules; 
 View results – shows the analysis report; 
 Validate results – after terminate the blood analysis process, the 
technician analyses and validates the results if the results are 
accurate; 
 Restart – In the case of an error or if the results are not accurate, 
technician can reinitiate the analyses process. 
In the Figure 10, we can see a scheme that shows the package, the 
respective use cases and the involved users. 
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Start
Stop
Restart
Status
View results
Validate results
HemoSpec System
Thecnician
Clean
Collect results 
 
Figure 10 - Use case diagram for the HemoSpec Device Package 
 
Finally, we will describe the HemoSpec system package that contains all 
use cases related with data mining and background process, which are the 
last step of the treatment’s workflow. We present follow a list that shows all 
the use cases presented in the package: 
 Data fusion – represents the join of all patient’s data; 
 Data Storage – storages of the patient’s data in the database; 
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 Classification – use case that represents the data analysis process and 
the respective patient’s condition classification; 
 Treatment – notification that the patient’s workflow is concluded. 
However, inside this package exists a sub-package that represents the 
Notification package, where the use cases related with the communication in 
the system are included (Figure 11). 
 Create – creates a notification and updates the workflow status; 
 Add – notifies the respective user after the creation of the notification 
by the system; 
 View – represents the visualization of the notification; 
 List – list of all pending notifications. 
In both packages, only the “HemoSpec system” has access to all use cases. 
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Data fusion
Classification
Treatment
HemoSpec System
Data Storage
Create
Add
View
List
 
Figure 11 - Use case diagram for the HemoSpec system package 
 
2.9.3. Activity diagram 
Since we already described both the use cases and the use-case diagrams, 
now we will describe the activity diagram. This diagram shows a complete 
scheme that describes the normal system's workflow [8]. Specifically, we can 
notice that the diagram represented in the Figure 12, includes multiple 
interactions among physicians, technicians and the system. 
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The workflow starts with an initial interaction of the physician, he creates 
the patient workflow. After the patient workflow is created by the physician 
is necessary that the workflow continues to working and for this the physician 
starts the patient workflow. All these actions will be considered by the 
HemoSpec platform that will process respective actions and processing the 
workflow. So, to continue the workflow the HemoSpec platform will going to 
notify the technician that exist a new workflow running and that he should 
maintain the same. Upon receipt of the notification, the technician will clean 
the device for after can start the device that will do a new blood analysis 
process. During the analysis process all users can see the status of the 
analysis. After completion of the analysis process the HemoSpec platform will 
collect all results and present these results to the technician. When the 
technician analyzes the results he takes a decision if the data are correct or 
not. If the data are not correct executes another analysis process, else 
validates the results. Afterwards the validation, the HemoSpec platform 
going to store the data and after the storage process doing a data mining 
process, calling of "classification". Finally, when the results are provided to 
the physician, the physician only has to consult results and takes an 
appropriated decision to the patient condition. 
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Create patient 
workflow
Start patient 
workflow
Notify technicianStart device
See 
workflow 
status
Collect resutsView results
Data storageClassification
Verify 
data?
Correct data
Provide results
Incorrect data
Physician consult 
results
Clean Device
Running 
device
After Processing
Validate Results
 
Figure 12 - Activity diagram for the HemoSpec workflow 
 
2.10. Mockups  
After analyzing all requirements, we had in consideration all information 
obtained and we started to draw the respective mockups. 
To build mockups, we decided to use Pinegrow Web Editor2, which is a 
modern editor that allows to create responsive websites in a faster way. For 
each page we can incorporate specific frameworks like Bootstrap 3 , 
Foundation4, etc., which turns the interface appellative. We can create a 
website only doing drag and drop of the elements, still having access, at the 
same time, to the generated code.  
During the mockups development, we defined initially three main pages. 
The first page is the login page that ensures a secure access to the platform, 
                                                        
2 http://pinegrow.com  
3 http://getbootstrap.com  
4 http://foundation.zurb.com  
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after login page, we divide the platform in another two pages, patient page 
and device page like we can see in the figure below. 
 
Figure 13 - Scheme of mockups structure 
 
How we can see in the Figure 13, patient page still has more two pages 
associated. The details page shows all information related with a specific 
patient’s consult and presents data obtained instantaneously during the 
analysis process. The module details page shows information related with a 
specific analysis module where technician can add comments related with 
this specific module results. Below we will explain and show all mockups 
pages. 
So, we will start to show the login page (Figure 14) that validates the user 
data access. If user data are validated, he will be redirect to the patient page. 
Otherwise the same page will be reloaded. 
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Figure 14 – Login page 
 
After correct authentication, the user has access immediately to the patient 
page, where he can observe all patients under study. In the Figure 15, we 
present the several states that a consultation can have during all the patient’s 
workflow. 
 
Figure 15 - Patient page, where we can see the several diagnostic phases 
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A consultation is automatically associated one respective analysis, which 
provides information about the entire analysis process. To visualize this 
information, users access to the details page and observe the current state of 
each analysis module. In Figure 16, we visualize that 2 modules have already 
terminated its analysis, but the analysis process continue running because 
there still are modules under processing. 
 
Figure 16 - Details page that shows all analysis information associated with a specific consult 
 
Like we see in the figure above the analysis continuing running. Whereby 
each user can consult the module’s details page associated with the 
terminated modules and visualize the information of the respective modules, 
represented in Figure 17. 
  
0    
 37  
 
Figure 17 – Page that expresses information of a specific module associated with a specific 
consult 
 
After all modules terminate the analysis, HemoSpec system saves the 
results in the database, allowing technicians to consult these data through 
HemoSpec platform. It still permits the technicians to take a decision 
accordingly to the results. The technician will validate results if all is correct 
or he/she will re-initialize the analysis process in the case of any specific 
parameter or result is incorrect (Figure 18). 
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Figure 18 – Section page when technician has to validate data or reinitialize the analyze 
process 
 
Once that technician validates results, the platform shows immediately the 
page that presents the automatic classification results to the physician 
(Figure 19). After analyzing these results, the physician submits an 
appropriated decision to this case. 
 
Figure 19 – Section page when physician see the final results and can take a decision 
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During all the analysis process, users can also visualize and explore the 
device page, where they can see the current state of each module and can 
consult the historic associated (Figure 20). 
 
Figure 20 - Device page that shows all information related to device
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Chapter 3 
 Architecture Proposal 
Based on the requirements presented in the last chapter, we will propose 
an architecture that complies with all features required by the project. With 
the objective of building a fast and natural platform that respects all 
requirements and ensures a user-friendly user interface, we need to have in 
consideration the chosen technologies that will be responsible for the core of 
the application.  
 
3.1. Overview 
As already mentioned, our solution is based on a web platform, composed 
by the client and server side.  
On the one hand the client side is the part that represents the user 
interface through which each end-user can interact directly using their web 
browsers. On the other hand, the server side ensures the management and 
data storages in the database. We use the MySQL5 database for managing 
and interacting with data stored in the system. The server side also ensures 
a communication protocol. 
In the Figure 21 we present a general overview of the architecture. During all 
communication between client and server side the exchange of data is made 
using the HTTPS protocol, which ensures the confidentiality, anonymity and 
security of data using authenticated and authorized services, avoiding its use 
by third parties [9]. 
                                                        
5 http://www.mysql.com  
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Figure 21 - General overview of the HemoSpec Platform architecture 
 
3.2. Client 
When building a web-based application, two of the majors concerns focus 
on the usability and user-interface. On the one hand, we must ensure that 
when we will develop the platform, this has to be more user-friendly as 
possible. On the other hand, performance issues, such as slow data 
representation, should be taken in consideration, since they could 
compromise the usability of the solution. 
To resolve all these issues and limitations our solution provides an 
innovative and flexible platform, since it is easily available for most devices 
with an internet connection. On the other hand, performance and 
supportability are key-factors that we must be aware of while developing our 
application. Thus, we choose standard web technologies, making HemoSpec 
Platform supported by the most widely used web-browsers on the market. 
This way, in our platform we use HTML5 that will structure and present 
the content in the page and we use CSS3 to format and give visual meaning 
to the content. To ensure a good interaction with user interface, we use 
JavaScript that will control the dynamic content, ensuring an asynchronously 
communication with the available services and after the invocation of these 
services update the platform content. 
These technologies allow us to create a widely supported platform, 
however, it is very important to assure that the same standards work in 
different browsers. Nonetheless, even though these technologies deliver fast 
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representation of information and cross-browser support, performance issues 
can emerge with large amounts of data. Thus, the development and 
implementation of fast and optimized algorithms are crucial to maintain a 
fluid application and enable fast load and visualization of data. Moreover, a 
web platform which includes all the requirements listed in the previous 
chapter can achieve a few thousands of lines of code on both server and client 
sides. Likewise, if we are building a web platform using JavaScript – like 
HemoSpec – it is extremely important to use an architectural pattern that 
add structure to all the data and facilitate the management of the code. 
 
3.2.1. JavaScript 
Since developers began to use JavaScript, most of the interactions 
between users and web platforms are performed faster. An important 
JavaScript fact is that tasks are executed faster, because those tasks are 
processed and completed almost instantaneously on the client side what 
avoids processing data on the server-side and sending again to the client side. 
This situation avoids consuming local, as well as server, bandwidth and time.  
Traditionally, web applications leave the heavy-lifting of data to servers 
that push HTML to the browser in complete page loads. This way, the use of 
client-side scripts was limited trying to improve the user experience. 
Nowadays, this relationship has been inverted, client applications pull raw 
data from the server and then render it into the browser when and where it 
is needed. 
In relation of the asynchronously communication until recently the most 
used forms to control asynchronous operations was through callbacks. The 
big problem of using callbacks is that when we have to chain multiple 
callbacks the code stays very hard to follow and understand. The solution 
used for us are promises that avoids the callbacks problems [12]. After we 
compare some libraries [13], we choose the bluebird library [14], since in 
general is the best. We present in the Figure 22 the comparison of the last 
versions on the Chrome browser, but you can consult comparison of all 
versions in the link. 
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Figure 22 - Comparisons between several promises libraries (blue – Bluebird, red – Pimp, 
orange – Q and green - RSVP) 
 
To manage all code that produces the platform and that complies with all 
requirements listed in last chapter, we adopted a Model-View-Controller 
(MVC) architectural pattern that simplifies the structure and management 
of the code [15], [16]. This pattern divides the application in three parts: 
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 Models, which represent the knowledge and data in an 
application, like an Organization, a patient, etc. Models advise 
other parts of the application when their state changes. 
 Views, representing the user interface of the application. The 
views update the user interface when occurs a change in the 
models. 
 Controllers, which handle events that occur in the view (e.g., user 
actions) and invoke the respective update in Models. 
 
In our solution, we decided to implement RequireJS6 in order to improve 
the speed and quality of the code [17]. RequireJS is a modular script loader 
that avoids repeating the "includes" scripts in each HTML file. For example, 
if we have 2 pages and we need to import jQuery7 and Bootstrap8 files to both 
pages, we only need to create a JavaScript RequireJS file where we write each 
include. So, with this strategy, we only need to include the reference of the 
JavaScript RequireJS file created on each page, and we avoid to repeat write 
several times each include. Also, we integrate WebJars9 that allows loading 
dynamically each necessary library to each page, what ensures a faster 
platform.  
 
3.2.2. User interface 
Our application is designed to be simple and easy to use, providing a 
comfortable user experience while helping users to use the platform. In order 
to create a fluid interface, we take advantage of several high-end technologies 
regarding to front-end developing and templating, such as: 
 jQuery: jQuery is a fast, small and feature-rich JavaScript 
framework designed to simplify the client side scripting of HTML. 
It makes things like HTML document traversal and manipulation, 
event handling, animations, etc. jQuery is behind over 70% of the 
                                                        
6 http://requirejs.org 
7 https://jquery.com  
8 http://getbootstrap.com  
9 http://www.webjars.org  
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most visited websites10, making it the most popular JavaScript 
library currently used 11 . jQuery also permits connect 
asynchronously with the server, through AJAX12 calls. 
 Handlebars: Handlebars13  is a JavaScript library for building 
semantic and intuitive templates that facilitate the developers 
work to build their user interfaces. Handlebars is compatible with 
Mustache template system.  
 Bootstrap: Bootstrap is the most widely used framework for front-
end developing. It contains HTML and CSS-based design 
templates for typographic forms, buttons, navigation and other 
interface components, as well as optional JavaScript extensions. 
The mostly components and features support cross-platform and 
support the most used browsers in the market. 
 
3.3. Server 
The server side of the application is responsible for storing all the data in 
a unique resource, moreover it provides services for the application 
interaction with that same data. Therefore, we need to design an architecture 
capable of support simultaneously data storage, provide a quick access to data 
and be of easily integration with every standard application, such as web and 
desktop. 
We use a MySQL relational database to storage and retrieve all data and 
simultaneously keep the data consistent over the time. To ensure a secure 
and homogeneous access to all the application information we need to create 
methods and services that will handle and manage all the data. Thus, we 
develop the several methods in Java, creating RESTful14 web-services. They 
are deployed and available through Netty15 web server. 
                                                        
10 http://www.similartech.com/categories/javascript  
11 http://w3techs.com/technologies/overview/javascript_library/all  
12 AJAX (Asynchronously JavaScript and XML)  
13 http://handlebarsjs.com  
14 REST – Representational state transfer 
15 http://netty.io  
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The use of REST web-services ensure an easier and faster access to 
storage data and also simplify the integration with several development 
platforms. 
RESTful APIs16 follow a set of standards [18]. They are defined using a 
base URI17 (e.g., https://localhost:9443/patient/), an Internet media type (e.g., 
JSON18, XML19) to send data between client and server side and also standard 
HTTP methods (e.g., GET, PUT, POST, DELETE). In the table 4 we 
summarize how these methods are used. 
Table 4 - How HTTP methods implement a RESTful API 
Resource URI     https://localhost:9443/ patient/id 
GET Obtain information of the patient according with the 
requested id and the information is presented in an 
appropriated Internet media type. 
PUT Update data of the patient according with the id. 
POST Insert a new patient in the database (do not use id in 
this method). 
DELETE Delete the patient with the id. 
 
Thus, using a RESTful web-services we can provide several methods 
allowing an appropriated access to the application data, at the same that we 
grant a secure and controlled way for the client-side application to exchange 
data with the server. On the other hand, the application data and information 
are very sensitive. Thus, we need to carefully control the access to the web-
service methods and hence, to the database. Therefore, and since we have 
users with different access permissions, we need to control the access to the 
different web-services methods. So, to ensure that this role is correctly 
applied, we incorporated a RBAC20 plugin, developed in the University of 
Aveiro by the bioinformatics group21. This plugin filters the access to specific 
methods according to the user permissions and guarantee that any change in 
                                                        
16 API – Application programming interface 
17 URI – Uniform resource identifier 
18 JSON – JavaScript Object Notation (http://json.org ) 
19 XML – Extensible Markup Language (http://www.w3.org/XML ) 
20 RBAC – Role based access control 
21 http://bioinformatics.ua.pt  
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the database is performed by a user with the right permission, preventing 
possible attacks.  
In order to ensure a full protection in the data transference between client 
and server side, we use HTTPS22 over HTTP methods because guarantee that 
the data transference occur in an encrypted channel. 
 
3.3.1. Services 
We develop Java web-services with the objective to ensure a correct and 
secure exchange of data with database. When we develop the Java web-
services we had in attention to use Jersey23 that is an implementation of JAX-
RS24. Jersey simplifies the development and deployment of web services. 
The several developed services are deployed and available using Netty 
server. During the development we separated services by different packages: 
 Account: in this package we have methods that allow showing and 
managing user data, like update user data; 
 Login: this package provides methods for controlling the access to 
the system; 
 Manage: this package represents methods related to the system 
administration, where only administrator has access to these 
methods. So, the administrator can access methods like create 
organization, edit organization, add devices, edit devices, invite 
users to the organization, edit users ,etc.;  
 Patient: the patient package offers methods that allow managing 
patient data. Thus, this package provides methods like create a 
consult, assign user to a consult, add a patient ,etc.; 
 Simulator: this package provides methods that control all the 
communication between HemoSpec Platform and HemoSpec 
Device; 
                                                        
22 HTTPS – HyperText Transfer Protocol Secure 
23 Jersey – https://jersey.java.net  
24 JAX-RS – Java API for RESTful Web Services 
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 Details: this package represents methods related to patient 
analysis. So, it represents methods like start an analysis, 
technician validate analysis results , technician write comments 
associated with a specific module results or physician submit 
analysis results; 
 Device: this package provides all methods related to the device 
that represents the interaction between device and users, like stop 
device, reset device, clean device, etc.; 
 
3.3.2. Data structure 
In this sub-section, we will show how our database is structured and 
organized. The database is centralized in the organization (Figure 23), since 
all information in the platform is dependent of the organization.  
An organization can have multiple associated roles, which are assigned to 
different users. Since, to each user is assigned roles according to their 
respective privileges. Thus, only users with specific roles may interact with 
the device organization. On the other hand, only users with the Administrator 
role can add users to an organization. In turn, each patient can have multiple 
consults associated, which informs users about the state of the patient. Their 
consults are simultaneously associated with the organization. 
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Figure 23 – Database relations with organization 
 
As we referred in the last paragraph, one organization can have several 
roles. However we can see that each role is different from another, since each 
role has specific permissions associated. All permissions are different 
between them because each permission has associated one specific operation 
and one specific category (Figure 24).  
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Figure 24 – Database sub-structure imported from RBAC plugin 
 
Now, that we already described all direct relations of the organization and 
role, we will describe the relations associated with a consult (Figure 25). 
A consult has associated one historic, in which are registered all the 
actions executed under the respective consult. On the other hand, a consult 
also has associated one analysis that contains all data provided during the 
analysis process. 
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Figure 25 - Database relations with consult 
 
As described in this document, one analysis is elaborated by four different 
modules, which implies that is necessary to store all the information 
associated with each module (Figure 26). 
 
 
Figure 26 – Database relations with analysis 
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3.3.3. Communication protocol 
The communication protocol guarantees that the exchange of data is done 
in a proper way, respecting all communication requirements. So all 
communications will be performed through REST web-services, on top of 
HTTPS in the way to ensure data security and privacy. The communication 
protocol is implemented over a master-slave architecture  [19], where we have 
one master (software controller) and four slaves.  
The communication protocol uses just one data format that enables a 
consistent communication throughout the platform. However, this does not 
affect the way like each slave produces its own data, since each slave will be 
associated with one communication interface (Figure 27), that is responsible 
for doing the translating from the data format produced by the slave to the 
data format applied in the communication protocol. Each communication 
interface is not more than a simple HTTP server that implements REST 
services.  
 
Figure 27 - Implementation of communication interface in each slave 
 
In the Figure 28 the master, Software Controller, represents the server 
side of the HemoSpec Platform, while each slave represents a device module. 
We can see that every module can communicate with the software controller, 
enabling storage and data exchange. However, we also enabling the 
communication between slaves, avoiding that all communication passes by 
the software controller. For example, if the Microfluidic separation slave 
needs to send some data to the holographic slave, they just have to exchange 
data between each one. This fact is much important because communications 
R
EST
J
S
O
N
R
EST
J
S
O
N
R
EST
J
S
O
N
Communication 
interface
Fluorescence 
spectroscopy 
module
Communication 
interface
Holographic
module
Communication 
interface
Raman
module
R
EST
J
S
O
N
Communication 
interface
Microﬂuidic 
separation
ARCHITECTURE PROPOSAL 
 54 
are considerably faster than using the software controller as proxy. 
 
Figure 28 - Master/slave HemoSpec architecture 
 
Once described the architecture master/slave used in our solution, we will 
now describe the various status that characterize each component. Also, we 
will describe which methods are used to obtain information associated with 
each components’ statuses and which methods allow to provide information 
to each component, allowing to ensure a correct working of the solution. 
Firstly, we will describe the different slave statuses, which express every 
action or slave’s status. Follow we present a list with the various status: 
 Operation status; 
 Clean status; 
 Blood sample availability; 
 Results availability; 
 Resources availability. 
 
The “operation status” allows to control and verify in real time the 
operation associated with each specific slave. A slave has associated 9 
different operation status: 
 Ready – when the slave is prepared to start another analysis; 
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 Error – when occurs a problem during the analysis process; 
 Lost connection – when the slave is disconnected from the master; 
 Initializing – this status only occurs when the slave is turned on, 
when execute initial configurations; 
 Processing – this status represents the execution of an analysis; 
 Cleaning – a slave has associated this status during the clean 
process; 
 Sending – when one slave sends information directly to other slave; 
 Receiving – when a slave receives  important information from other 
slave to continue the process; 
 Waiting – a slave already finished the analysis process and wait for 
new orders; 
 Stopped – when a user stop the slave; 
 Finished – when the slave finishes the analysis process. 
 
The second status presented above is the “clean status”. This status 
informs if the slave is clean or dirty. After a slave starts an analysis the clean 
status changes to dirty. On the other hand, if a specific slave is cleaned the 
status change to clean. 
The status described in the last paragraph is much affected by the “blood 
sample availability status”. This can exchange between 2 different values, 
with or without sample. So, when a slave is clean, meaning that the respective 
slave does not have any sample associated, on the other hand, when a slave 
exchanges the clean status to dirty meaning that the slave has the sample 
associated.   
During the analysis process can be necessary has additional resources 
associated with the slave. This way, each slave has associated the “resources 
availability status” that indicates if the slave has any resource in its 
possession (with or without). 
Finally, we will describe the “results availability” status. Basically, this 
status indicates if the slave already has in its possession results or not (with 
or without). 
After we had described the different statuses used to control all the 
process, we will present the various methods types that control all 
communications during the process, all the methods are executed by the 
master. In specific, we have 6 different types of methods. 
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The first method type is the “availability” method that allows informing 
the master about the availability of each slave (on, off, ping, etc.). The second 
method type is the “state” method that expresses the state of the device 
(initialized, cleaned, reseted, etc.). Another method type is the “status” 
method that allows to “get or set” statuses associated with different slaves. 
The device also has associated the “blood sample” method type that provides 
information about the analysis process. The fifth method type is the “data 
exchange” method that permits 2 slaves communicate directly without 
contacting the master during the communication. Finally, the last method 
type is the “configuration parameters”, which allows to get or set parameters 
of a slave. 
Summarizing, with master/slave architecture we allow that each slave 
communicates simultaneously with the master (software controller) and 
between themselves enabling consistent communications. 
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Chapter 4 
 HemoSpec Platform 
In this chapter we describe the HemoSpec Platform, a web-based platform 
that was developed to fulfill the requirements identified in the chapter 
“Requirements analysis”. First, we will describe the main actors as well the 
workflow that was used to guide the system development. Afterwards, we will 
describe the communication protocol used between the platform and the 
device. After this, we show and describe the user interface and finally we 
explain how we implement security in our services. 
 
4.1. System description 
HemoSpec Platform is a web-based platform with the objective to create 
a solution that centralizes and speeds up the treatment process of sepsis 
disease. In the way, to speed up the process, all analysis will be done in a 
unique device that exchanges directly results with the platform. The data 
exchange uses a communication protocol that will be described later. Do not 
forget, that the developed platform was designed with focus in the usability 
and user friendliness, in order to ensure that the interaction with users will 
be simple. Also, we had in account during the development the necessity of 
implement optimized methods to guarantee a fast and efficient solution 
processing. 
In our solution, each user, device or patient is associated with one specific 
organization (Figure 29). In one organization, we can have three different 
types of users, from the administrator until the technician. The physician and 
the technician have the responsibility of controlling the consult and device 
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workflow which are associated with a patient’s study. While the 
administrator besides of these responsibility already described, he still has 
different responsibilities associated. He is responsible for managing the 
organization and for managing users associated to the respective 
organization.  The administrator also is responsible for managing the device, 
for controlling patients associated with the organization and for defining roles 
associated with the organization (physician, technician, etc.). To finalize, 
associated with a consult we have one analysis and the respective historic 
that contains all the actions executed under the consult. 
 
Figure 29 – Basic scheme followed by HemoSpec Platform 
 
In the next three figures (Figure 30, 31, 32), we present the normal 
workflow followed by our application. So, we will start by the first figure that 
represents the initial phase of the workflow.  
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To start the normal workflow users adds a patient to the system, which 
respectively will be associated to one organization. After the respective user 
adds the patient, any user can continue the workflow. To continue the 
workflow a user only needs to click in the button “Request study” and 
automatically the patient study/consult will be initiated. At this moment, the 
patient consult status exchanges to Requested due to the click did before. The 
last step represented in this figure is associated with the click in the “Assign” 
button. This click will update the workflow, at the same time exchanges the 
status from Requested to Assigned. 
Note, when we want to start a patient workflow and the patient is not in 
the database, like we assume in the last paragraph we have to add the 
patient. However, if the patient already exists in the system, to start the 
workflow a user just needs to click directly in the “Request study” button. 
 
Figure 30 – First section of HemoSpec workflow 
 
Now that a consult already is in the Assigned status, to continue the 
workflow, the technician has to start the analysis (Figure 31), by clicking in 
the “Start study analysis” button. When the technician clicks on the button 
instantaneously the platform turns on the device that processes the analysis. 
During the analysis process both users can visualize the consult and 
device status. However, only the technician can manage the device during the 
analysis process. When the analysis terminates, the system change 
automatically the consult status to waiting technician. After, the technician 
going to take a decision according with the observed results. Depending on 
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results, the technician can do a reanalysis what going to repeat all the process 
or if results are good can validate them. Since technician validates results, 
the platform will assume this decision and going to change the consult status 
to waiting physician. 
 
Figure 31 – Second section of HemoSpec workflow 
 
 The last step of the workflow is based on the physician decision (Figure 
32). First the physician will see the analysis results and the comments of the 
technician. Finally, the physician will take a decision according with results. 
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Figure 32 - Third section of HemoSpec workflow 
 
4.2. Communication protocol description 
A communication protocol is fundamental to assure a successful 
transmission of data in a system, where is respected the data format, the 
speed of transmission, the quantity of data exchanged, etc. All these 
restrictions guarantying a consistent communication in a system. 
In our solution to ensure consistent communications and that all rules are 
respected, the communications between components are always started by 
the master. Thus, the master has control and knowledge about all 
communications that are occurring in the system. And every time, the master 
can intervene in the communication, guarantying that all is fulfilled correctly. 
As we described in the section 3.3.3, in our platform the modules can 
execute several different methods to satisfy all necessities. But, it is not 
objective of this document describes how all these methods communicate. So 
to avoid the descriptions of all these methods, we group the various methods 
by different groups. More in concrete, we have 4 groups that symbolize all the 
different communications that occurs in the system. Follow we will describe 
one method associated with each group and simultaneously presents a basic 
diagram that shows the communications executed by the method.  
The first method (Figure 33) that we will describe is the “ping” method. 
As is any communication, the master initializes the communication with the 
slave. The master invokes the “ping” method, subsequently the slave receives 
this invocation and will process the respective method. When the slave 
finishes the processing, he sends the response to the master. After the master 
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receives the response, he updates the information and continues the 
respective workflow. 
 
Figure 33 - Description of the ping action using the communication protocol 
 
The next figure describes the “parameters” method, which has the 
objective to update the slave data. This way, the master sends information to 
the slave invoking the respective method. Follow, the slave will update its 
data with the parameters received from the master. Finally, the slave will 
advise the master that already updates its data.  
 
Figure 34 – Description of the set parameters action using the communication protocol 
 
In the Figure 35, we will describe the clean action executed over a slave. 
More one time, the master starts the communication with the slave, this time 
through the invocation of the clean method. When the slave processes this 
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method, he will change the operation status to “Cleaning” and following 
return the operation status to the master. Afterwards, the master will invoke 
the “status” method to know if the slave already terminates the respective 
operation. So, when the slave terminates the clean operation, he will change 
several status associated to him like shows below. This way, when the master 
invokes this method and the slave finishes the operation, he will return the 
several statuses changed, updating the master data. 
 
Figure 35 - Description of the clean action using the communication protocol 
 
The last method that we will describe (Figure 36) is related to the data 
exchange between slaves. This method has the advantage of not involving 
directly the master, since this only tells initially to the slave 1 to send data to 
the slave 2, what allows that the communication will be faster than compared 
if was needed to use the master as proxy. Afterwards, we will describe all the 
communications realized to execute this action. 
Firstly, the master invokes the “send” method to the slave 1 where 
informs who is the slave that will receive the data. After the slave 1 receives 
this invocation, he will change the operation status to sending and he will 
establish a communication with the slave 2 through the “receive” method. 
When the slave 2 processes this message, he will change the operation status 
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to receiving and send the confirmation message to the slave 1. After the slave 
1 receives this confirmation, he also will send a confirmation to the master. 
While the exchange of data process occurs, the master continues invoking the 
“status” method that we already previously mentioned, but in this case there 
is no data to update (get). 
After the exchange data process finishes, the slave 2 exchanges the 
operation status to waiting and invokes the “status” method to the slave 1 
(set), where send the respective operation status, allowing that slave 1 update 
also its operation status. 
From this moment, when the master consults the status of each slave, 
they send the new operation status and respectively the master updates data. 
 
Figure 36 - Description of exchange data between slaves using the communication protocol 
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4.3. User interface 
The user interface is much important in our solution, because it is 
through of the interaction with the platform that users interact with the 
system. If the interaction between users and the interface is not good enough, 
users do not take advantage of the solution. This way, it is necessary to have 
into account the usability of the platform and at the same time ensures that 
the platform is user-friendly, guarantying that interactions will be intuitive 
and direct. 
In this section we will present details of HemoSpec Platform’s user 
interface and respective interactions. Also, it is important to refer that we will 
describe more pages than we showed in the mockups section. We created more 
these pages with the objective of complements our solution. 
 
4.3.1. Patient page 
After we make login (Figure 37), the platform redirects us instantaneously to the 
patient page. 
 
Figure 37 - Login page 
 
The patient page (Figure 38) is the base page of our platform, since this 
presents the basic and relevant information of patients. Thus, in this page we 
can visualize the information of each patient, in the current moment.  
HEMOSPEC PLATFORM 
 66 
To facilitate the search for a specific patient or search for patients that 
are in a specific consult status like Requested is adequate to use the search 
tool, that apply a filter with the required parameters about patients data. 
Also, it is possible any user adds a new patient, provided that, the patient is 
not already added in the respective organization. 
 
Figure 38 - Patient Page 
 
As we can verify directly in the figure above, in specific in the first page 
of the pagination, does not exist any study in processing. This information is 
perceptible since all patients wait for a new study (“Request Study”). On the 
other hand, in the same page if there existed a patient in specific in the 
Requested status, this same information was visually acquired of a direct 
form because we saw a different label in the status column. 
However, like we can understand in the system exist much patients 
associated. So we have more than one page with patients, what do not make 
clear of visualize if exist some patient’s consult in the Requested status. 
Which implies that each user when do login in the system, he have to verify 
always if exist one or more patient’s consults in the same situation. 
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To counter the situation described in the last paragraph, it was 
implemented in our platform a gender of a notification (Figure 39) that 
informs directly users, in specific technicians, that there are studies to follow 
( consults in the Requested status). 
 
Figure 39 - Notification that there are studies pending 
 
Assuming that there is one study in the Requested status (Figure 39) and 
this will be continued, then a user will click on the assign button. After he has 
clicked on the button, the status of patient consult will change to Assigned 
and at the same time, the notification presented in the last figure will be 
removed (Figure 40), since that this study is now being accompanied. 
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Figure 40 – Patient’s consult is in the assign status 
 
From this moment, the technician can start the analysis process 
associated with the study. To access the details page, where it is possible to 
start the analysis, the technician has to click on the details button associated 
with the respective consult (Figure 40).  
 
4.3.2. Details page 
Now, that we already described the patient page and following the 
HemoSpec Platform workflow (Figure 32, 33, 34), we will start for describing 
the details page. 
After the patient’s consult exchanges to assigned status, all users can 
access to the details page, but only technicians can start the respective 
analysis. Thus, when a physician access to this page and the consult is in the 
referred status, the platform disables the button “Start study analysis” 
(Figure 41) because the user does not have the right permissions to start the 
correspondent analysis.  
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Figure 41 - Physician tries to start an analysis 
 
Assuming that the technician accesses to the page to start the analysis, 
the platform renders the web page and at the same time it will see if some 
device is associated with the organization. If any device is associated, the 
platform presents an alert message (Figure 42).  
 
Figure 42 – Organization does not have device associated 
 
After the platform finds that one device is associated with the 
organization, this will verify if the device is ready or not. If the device is not 
ready can show one of figures 43 or 44. 
 
Figure 43 - Device is not ready to start an analysis 
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Figure 44 - Device does not contain the blood sample 
 
After the platform makes all verifications and concludes that it is all ok 
to start the analysis, it presents the Figure 45. 
 
Figure 45 - Technician can start the analysis 
  
Considering that the technician starts the analysis, instantaneously the 
platform realizes the respective actions. This way, the platform will be 
updated (Figure 46). 
 
Figure 46 - Details page informs that the analysis is processing 
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 During the update, the patient consults exchange the status, but now 
to running status and the device is started, like we see in the Figure 46. The 
device is responsible for doing the analysis and provides information to the 
platform. As we can see above, the analysis is divided in two parts. First, the 
device will make a separation of the different microfluidics presented in the 
patient blood. Just after, of this has concluded the separation is that starts 
the second part of the analysis. When the device terminates the microfluidics 
separation, it will update modules status. This way, the microfluidic 
separation module will finish the processing and will start the processing of 
the others (Figure 47).  
 
Figure 47 - Microfluidic separation module terminates its process and starts the other 
modules 
 
Now, that one module has already terminated its processing, each user 
can consult the specific module results by clicking on the “Analysis results” 
button. After click on the button, the platform shows other web page that 
contains all the analyzed module information and where it is possible writes 
comments associated with the results. However, only the technician 
associated with the study is that can write the respective comment (Figure 
48). 
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Figure 48 - Module details page, which presents module results and where the technician can 
write comments related to results 
 
When the platform visualizes that all modules already finished the 
analysis instantaneously will update the data. Following, the platform 
automatically will present a new section (Figure 49), where the technician 
can write his decision according with the results and respectively select the 
correct choice for this study. 
 
Figure 49 - Technician validation 
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Considering that the technician validates results, the platform 
instantaneously will assume this decision. At the same time will initiate an 
automatic classification of the results provided by the device. When this 
classification is concluded, the platform will present the results obtained to 
the physician (Figure 50).  
 
Figure 50 - Physician decision 
 
Now that the platform presents the results classification of the current 
study, the physician already can take a decision according with the results to 
apply in the patient treatment. 
 
4.3.3. Device page 
On this page, the platform presents information about the device status, 
in specific shows the status of each module. Even though there is not any 
analysis processing we can see the information of each module. The several 
modules can be in different status.  
This page is visible for every user registered in the platform, but only the 
technician and the administrator can execute actions over the respective 
device. As we referred each device module can present different status (Figure 
51), what shows that each analysis done in each module is independent of 
each other. However, in this web page all actions taken by the technician or 
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by the administrator are executed over the device in general and not over 
each module in particular. 
 
Figure 51 – Information of each module captured from the device page 
 
About the device, users can execute different actions, specifically we have 
3 different actions. The first is the stop action, represented by the Stop button, 
that allows breaking all the device processing, that is represented in the 
Figure 52.  
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Figure 52 – Device status after executed the stop action 
 
The second is the clean action that permits after finished the analysis or 
when the analysis is stopped clean the device (Figure 53). The last action is 
the reset, it allows that a technician can reset the device and simultaneously 
the analysis process (Figure 54). 
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Figure 53 - Device status after executed the clean action 
 
 
Figure 54 - Device status after executed the reset action 
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On this page, also it is possible to see the set of actions executed over the 
device. In each table row (Figure 55) is presented an action, the date of 
execution, the technician and the patient involved. The advantage of this list 
is that shows information of each action executed over the device. This way, 
when we need to know who is responsible for an action or when the action 
was executed, easily we consult this information. To facilitate the search 
method, associated with the table we have a search tool that allows to filter 
for any field associated with each row in the table. 
 
Figure 55 - list of actions associated with device 
 
As we expressed, in the device page users always execute actions over the 
device in general. Whereby, if a user wants to execute an action just over a 
specific module, he needs to access to the specific module device page by 
clicking in the settings button associated with the respective module. In this 
page (Figure 56), users see all the information associated with the specific 
module device. The big difference between this web page and the device page 
is that in this page all the actions are executed only in this module. 
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Figure 56 – Details page associated with a specific module  
 
4.3.4. User account page 
In the user account window (Figure 57), users can visualize own data and 
if necessary they can change their data. However, when a user changes his 
data, the platform verifies in real-time if the input data complies with all 
requirements. For example, when a user changes the email, it is required that 
the same follows a correct email structure or when a user changes the 
password is verified if the new password is different of the old password. The 
platform also verifies if the new password is a strong enough password to 
ensure the security on the platform. Only when all entered data is correct is 
that data can be submitted.  
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Figure 57 - User account page 
 
4.3.5. Management page 
Just users that have the administrator role can access to this page, 
because this is a restricted web page with the objective of control the 
organizations characteristics. As we can see in the next figure, just users with 
the respective role can see the Manage reference ( ) on the right side of the 
header. 
 
Figure 58 - Management page 
 
When an administrator accesses to the management page, what this user 
sees directly on the page is the list of organizations associated with the 
system. After the administrator analyzes the presented information, he can 
do different things. Thus, if the user needs to join more one organization to 
the system, he can easily add one organization. For this is enough to click in 
the “Add Organization” button. Note that, if the user tries to add an 
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organization with the same name of some existent organization, the system 
will alert that already exist an organization with this name. On the other 
hand, the user also can remove an organization, in this situation occurs 
something similar like in the action “add organization”. So if the 
administrator tries to remove an organization with data associated, what the 
platform does is alert the user and prevents this action. 
Finally, the user to consult organization data, he needs to click in the 
“Edit” button. After click on this button, the platform presents the 
information associated with the respective organization. In the next sections 
we will describe the information presented and associated with the 
organization. 
 
4.3.5.1. Users 
In this section ( ), the platform shows users’ information associated with 
the selected organization. Basically, an administrator in this page can do 
three different actions over users. The referred actions are add, remove and 
edit users. So, if an administrator wants to add a user, he just has to click on 
the “Add user” button and inserts the respective data. After the administrator 
inserts data, the platform will verify if all data are correct, in specific the 
platform checks if the user email is not repeated. Also, the administrator can 
edit user data or remove a specific user, but when he tries to do one of the 
referred actions the system verifies if the user is associated with some study 
in processing. If the user is associated with a processing study, the platform 
will prevent the respective action, in the way to ensure that the change does 
not affect the study. In the Figure 59, we show the described section. 
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Figure 59 – Users section integrated in the management page  
 
4.3.5.2. Patients 
The patients’ section ( ) will follow the same structure of the user 
section ( ), where we can do the same things. However, like the name 
expresses all the actions executed in this section are over the patients (Figure 
60). 
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Figure 60 – Patients section integrated in the management page 
 
4.3.5.3. Devices 
How we described before in this document, one organization has 
associated one device. Considering that the organization has already one 
device, when the user tries to add another, the respective platform prevents 
this action. Here, also it is possible to edit and remove the respective device. 
Note that, when a user adds a device, he had to verify if the same is 
connected, by clicking in the button Test Connection (Figure 61). Only if the 
device is connected with the platform and if all fields are correct is that the 
user can add the device. 
 
Figure 61 – Devices section integrated in the management page 
4.3   USER INTERFACE 
 83  
 
4.3.5.4. Roles 
The roles section ( ) is where the administrator can define the several roles 
associated with each organization (Figure 62). Associated with each role the 
administrator can edit which permissions he wants to connect. It is in the definition of 
these roles that the administrator indicates what actions each user can do. For example, 
in the figure below, we see that the technician and the administrator role have the 
permission edit the device ( ). While the physician role does not have this permission. 
So, like we saw in the device page all users can visualize the information about the device 
( ), but only the technician and the administrator have permissions to execute actions 
over the device ( ). Summarizing, the roles section is much important because it allows 
to define what each user with a specific role can do in the organization. 
 
Figure 62 – Roles section integrated in the management page 
 
4.3.5.5. Settings 
The section settings ( ) allows to see and edit data of the organization. 
So, when the administrator clicks in the “Settings” button, the platform 
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presents a modal (Figure 63) with the organization data and where the 
administrator can update these data. 
 
Figure 63 – Settings section integrated in the management page 
 
4.4. Solution security 
During the development of the platform, we always have in attention 
security and authentication factors. These factors are important in the 
platform because we need to assure that all the stored data and every 
connection between the server and the client are properly authenticated and 
secured. Another fact, it is that the platform has users with different roles, 
and each role has different permissions. In order to resolve all these problems, 
we implemented a role-based access control plugin to all the provided 
services. This way, we ensure that each method called from the client-side of 
the application is executed only if a user with the right permissions has 
requested the information, preventing security violation and assuring that 
the stored data are consistent and secure. 
As we expressed and described in the last paragraph, to ensure a flexible 
and extensible security platform, we implement the RBAC plugin.  This 
plugin only allows access to specifics web-services users with the correct role. 
This way, we needed to define the followed roles (Table 5): 
 Administrator: this role represents all HemoSpec administrators. 
They have full access to the application and simultaneously they 
have access to all methods; 
 Physician: this role is associated with users who are responsible for 
monitoring the patient process; 
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 Technician: assigned to all users who have the function of follow 
the patient analysis. 
Table 5 – Different roles and respective permissions in HemoSpec Platform 
Permission Administrator Technician Physician 
Add organization    
View organization    
Edit organization    
Remove organization    
Add user    
View user    
Edit user    
Remove user    
Add patient    
View patient    
Edit patient    
Remove patient    
Add device    
View device    
Edit device    
Remove device    
Add role    
View role    
Edit role    
Remove role    
  
In order to ensure proper authentication and authorization of the 
services, we assign the correspondent permission/permissions to each 
method. So, when a user accesses to the platform, the respective role is 
associated to him. Therefore, when a user invokes a method, the platform will 
verify if the user role contains some permission assigned in the method. If the 
platform verifies that the user has the right permission the requested is 
accepted, otherwise the requested is denied.  
Summarizing, with the implemented plugin we ensure that each web 
service are robust and secure. These characteristics provide trustful services 
and avoid undesired requests.  Moreover, the communication between the 
client and server is performed using a secured and encrypted channel using 
Hypertext Transfer Protocol Secure (HTTPS), in order to guarantee complete 
protection of the exchanged data.
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Chapter 5 
 Evaluation 
In this chapter, we will speak about the usability tests, heuristics 
evaluations and performance tests. Firstly, we will explain the importance of 
usability tests on the development of each platform. Also, we will explain the 
importance and the gains with the respective tests and we will present the 
results obtained from the realized usability tests. Secondly, we show the 
several heuristics covered during the heuristics evaluations and the several 
problems encountered. Finally, we present and analyze the performance 
results of the HemoSpec platform. 
 
5.1. Introduction 
The objectives of the usability tests and heuristics evaluations are to 
assess the design and test the system to ensure it behaves as expected. While, 
the performance tests demonstrate that the platform corresponds with the 
performance levels required. This way we need to evaluate the HemoSpec 
Platform. Evaluation is a development life cycle process and must be done 
according to principles and prototyping techniques because it is easier to 
change a design in the early stages of development that in later stages. This 
evaluation can be done by the designer or a usability expert (without final 
user interaction) and by a user who tests the actual use of the system [20]. 
One of the best and most popular ways to gather the maximum 
information is to observe users interacting with the system and analyzes the 
environment variables such as user’s facial expressions, their comments or 
screen footage. To provide useful insight into problems within an interface 
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and if it meets user’s requirements through their decision processes and 
attitude, we can use a Think Aloud method. This method collects users’ 
description about what they are doing, what they believe is happening, the 
reason behind an action of a particular task and what they are trying to do 
[20]. This strengthens the usability tests providing large amounts of 
information from many sources that illustrate well the system debilities. 
During the usability tests the tester observes users while they are using 
the system and find usability problems. However, can exist different types of 
tests defined by the development phase of the project, these tests can be done 
before development, during and after what affects the formality of the testing 
method [21].  
Formality in testing is the type of methodology where users are 
interviewed about the system, how they use it, how they like it and which 
kind of software they use. Normally, this is done in front of a computer while 
users talk about what they are seeing and doing. The tester notes user 
reactions, comments and mistakes, giving the participant progressively 
harder tasks over the course of the session. According to Steve Krug [22] 
usability tests must be done because testing is better than no testing and with 
an iterative testing process, a live audience analysis and a representative 
group of users, we can find almost all the problems – Steve Krug also refers 
that it is more important having a small group of users with several tasks 
iterations than a lot of users and too few iterations. 
Concluding, the importance of the several tests is to replan iteratively the 
current design and methodology, solving design and performance issues or to 
learn the weaknesses for the future releases [23]. 
 
5.2. Usability tests 
The importance and the gains of the user testing led to a testing and 
usability plan (appendix A.1) to be carried out by students of the University 
of Aveiro. This plan asks each user to complete a series of tasks while they 
are being observed by a tester who notes all important comments along the 
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execution of the task, goal achievement, need for help, number of clicks and 
ease of execution. 
Important and vital to the success of any user testing plan, users were 
selected with equal profile based on specific criteria to match the expected 
user population – similar age and level of education, experience with 
computers and technology domain [20]. 
When performing usability tests there are some problems that can be 
often found as users getting disoriented or confused about the user interface 
due to existing elements, the lack of them or if the functionality is not clear. 
The excess of information can also degrade the understanding of the user 
interface [22]. 
Keeping this in mind, the usability tests were performed to understand 
what was bad in the HemoSpec Platform, specifically where users failed 
during the test. It was also pretended to gather the maximum suggestions 
and observations about user experience during the test that could improve 
usability. 
The test was made by 12 engineering students of computers and 
telematics that interacted directly with the HemoSpec Platform. During the 
several tests with the students, the tester had to register the user 
performance for each task: 
 Number of clicks done; 
 Completion of the task – boolean value; 
 Mistakes made – quantitative by three ranges; 
 Got lost – quantitative by three ranges; 
 Call for help – boolean value; 
 Difficulty felt by the user as judged by the tester; 
 Relevant observations. 
It was intended to gather relevant information about performance over 
each task, and if the users found each one easy and accessible or if they had 
problems with task completion. The need for help and disorientation with a 
probable high number of mistakes, tells if the task must be improved 
functionally or the interface elements that are used. Users were also asked to 
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evaluate a set of interface characteristics (appendix A.1) of HemoSpec 
Platform using a qualitative scale from 1 to 5 where 1 has a more negative 
value and 5 has a more positive value. 
The results are illustrated by charts that use this scale.  
 
5.2.1. Results 
The users that test our platform having no experience with medical web 
platforms, which may affect the usability and functionality of the platform. 
However, the final questionnaire shows a positive reaction about the platform 
(Figure 64, 65). 
 
Figure 64 – Global classification of the platform 
 
8%
50%
42%
How do you rate it globally?
Bad Litte bad Sufficient Good Very good
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Figure 65 - Level of platform recommendation 
 
In the Figure 66 we can analyze the difficulty rate of tasks realized during 
the usability tests. The level of difficulty of each task increase along of the 
test, with the objective to verify if the user interacting with the interface 
understands how the platform works. Observing the results we concluded 
that in general all tasks were easy of doing. However, to confirm our 
expectations, we asked to different users if they felt the tasks easy according 
with their evaluations. The users explained that initial tasks were easy 
instead of the last tasks, but with the use of the platform they felt more suited 
with the platform. Thus, even the last tasks make it accessible. 
 
Figure 66 – Level of difficulty of the several tasks during the usability test 
8%
34%
58%
Would do you recommend it to someone?
Never Little Depends Indeed Sure
17%
33%
50%
How do you rate your tasks during the 
test?
Very hard Hard Medium Easy Very easy
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Based on the results presented in the Figure 67 and in the positive 
reviews received from the evaluators, we concluded that the platform design 
comply with the initially proposed objectives. In other words, we can classify 
the platform like an attractive and direct platform to the users. 
 
Figure 67 – Classification of the design of the platform 
 
As mentioned, the platform has advantages in being attractive and direct 
for the users. However, to guarantee these characteristics also is necessary to 
ensure an intuitive navigation along the platform. In the Figure 68, we can 
see a chart that presents the opinion of each evaluator in relation with the 
browsing platform. 
8%
50%
42%
How do you rate the main design of the 
platform?
Confused Little confused Clear Most clear Evident
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Figure 68 – Classification of the navigation in the HemoSpec Platform 
 
Finally, we can visualize in the last figure of this section (Figure 69) a 
chart that shows the values about the difficulty that users felt in understand 
like the platform works. 
 
Figure 69 – Level of difficulty of understand the platform  
 
 As previously mentioned, usability tests do not enable us to find all the 
problems which is why heuristic evaluations often take place to cover some of 
encountered problems [24]. 
 
8%
59%
33%
Was the navigation through the platform 
intuitive?
Rarely Few times Often Very often Always
18%
46%
36%
Is the platform hard to understand?
Very hard Hard Medium Easy Very easy
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5.3. Heuristic evaluation 
Usability tests are indeed important to find the major problems when the 
solution is still under development or at a beta stage. Other methods such as 
heuristic evaluations can be done in the early stage and in an existing design 
that detected problems can be fixed. Originally, heuristic evaluation was 
developed as a usability method for those who had some knowledge about 
usability principles not involving potential users in the tests [25]. 
According to Jeffries [26] and Desurvire [24], expert heuristic evaluators 
find more problems than any other evaluation technique, including usability 
testing [27]. This proves that evaluators trained in usability issues and 
heuristics principles find more problems than inexperienced users but these 
evaluation techniques are not accurate by themselves, and need to be used 
together: user’s lack of experience and the naivete using a novel application 
proves to be better at finding unknown or minor problems besides the major 
ones. 
A heuristic evaluation by trained evaluators was conducted to find the 
potential problems in the HemoSpec Platform, taking advantage of their 
skills and knowledge. This evaluation is based in the follow usability 
principles [28]: 
 Visibility of system status; 
 Match between system and real world; 
 User control and freedom; 
 Consistency and standards; 
 Error prevention; 
 Recognition rather than recall; 
 Flexibility and efficiency of use; 
 Aesthetic and minimalist design; 
 Help users recognize, diagnose, and recover from errors; 
 Help and documentation. 
Heuristic evaluation is not set to fix usability problems or to provide a 
way to assess the probable quality of any redesign but to explain each 
observed problem against the principles listed. Severity ratings can be used 
to provide an estimate of the need for additional usability efforts, using 
5.3   HEURISTIC EVALUATION 
 95  
factors such as the frequency the problem occurs, its impact and persistence, 
but it is common to combine all of them into just one, to facilitate prioritizing, 
and decision-making [29]. Basically, it is a 4 level scale: 0 rating means the 
evaluator does not think there is any problem with the interface; 1 reflects a 
cosmetic problem; 2 a minor usability problem; 3 a major usability problem 
and 4 means a usability catastrophe. 
The various problems encountered aim to highlight the weaknesses, 
evidencing improvements to the current user interface to become more 
efficient and user-friendly. The improvements ensure a cohesion between 
them and an operational flow that allows the user to use the application as a 
whole. The revision cycle of the design and implementation of these 
improvements should come in several iterations so that it is properly resolves 
and the integration of new functionality or services may be performed in a 
modular way and on a stable application. Let’s take a look at the results of 
the heuristic evaluation. 
5.3.1. Results 
With the collaboration of 5 engineering students of computers and 
telematics as evaluators, with the basic knowledge and academic training for 
the heuristics evaluations, the results convey a positive reaction to HemoSpec 
Platform, with few cosmetic and minor usability problems. 
Firstly, evaluators said that some of the buttons and labels should have 
more visibility, should be flashier, helping users to easily see the elements 
and the respective information associated with the element. Secondly, 
evaluators reinforced that will be beneficial in terms of platform perception, 
that when an action is associated with one justification (analysis restarts), 
the platform should advise users that have to write their decisions and only 
after they can execute the respective action. 
Other 2 issues are related to the number of clicks associated with certain 
actions. In specific, when in the patients page technicians are alerted that 
there are request studies pending, the platform when detects clicks over the 
notification should automatically does a search over the patients in this 
status. Avoiding that users after verifying the notification still they have to 
use the search tool to find patients associated. The other problem is on the 
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details’ consult page, when the analysis is in processing. If one of the modules 
changes to error or lost connection status should appear one button associated 
to the respective module. This button should redirect the user to the module’s 
device page, avoiding in this way that the user has to click on button device 
to go to device page and after click on settings button of the respective module 
to go to module’s device page. 
 
5.4. Performance tests 
A performance test can be realized in different types of applications, such 
as desktop or web applications. The same tests can be developed in several 
phases of the application development. 
We will focus just in the performance tests oriented to the web 
applications that satisfy our necessities. These tests are divided into 3 main 
types: 
 Load test – to verify  application behavior under normal and peak 
load conditions; 
 Stress test – to reveal application bugs that surface only under high 
load conditions; 
 Capacity test – to determine how many users and/or transactions 
a given system will support. 
According to a study done by the Nielsen Norman Group [30], the 
response times of the websites are divided into 3 different levels. Each level 
causes specific reactions in the users. The levels referred are as follows: 
 To 0.1 seconds – the user has the feeling that the response is 
instantaneously; 
 To 1 seconds – the system keeps users connected; 
 From 10 seconds – users wish that the page load will be fast. 
Nowadays, the performance of a site is mostly affected by the frontend 
and not the backend, like many people think. This is because all the data to 
be processed and presented to users is done in the frontend side. Note that 
80-90% of the time spent by users waiting for pages to load is responsibility 
of the frontend [31]. 
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Then, we will show the Figure 70, where we present a chart with the 
performance values of the platform. In our study, we use load tests since 
comply with our requirements, that evaluates the performance of the 
platform according to data growth. 
 
5.4.1. Results 
In the next chart, we present the response times that our platform delays 
to respond according to different number of patients. We compare 2 different 
requests, in the first request we just load patients’ data and in the second 
request we load the actions associated with each patient analysis. The second 
request is more complex which tends to be slower. 
After we visualize the chart that presents the values obtained from the 
performance tests, we can conclude directly that the respective chart is 
constituted by two sub-charts with different order of magnitude. Thus, the 
sub-chart represented between 0 and 1000 patients is of linear order of 
magnitude, while the other is of exponential order of magnitude. Let’s go to 
analyze the referred sub-charts. The sub-chart of linear order of magnitude 
compared with the times presented by Nielsen Norman Group complies with 
the requirements set, since the load time is practically immediate 
maintaining the user focused on the executed workflow. Concerning with 
other sub-chart already cannot conclude the same, since the platform 
performance with a patient number more elevated tends to be worse, which 
means that users get tired of the time that the platform takes to load the data. 
However, this platform is still in a development phase and it is integrated 
in a clinical project under study, where it is estimated that the number of 
patients in a short-medium term does not reach a high number, allowing 
comply with requirements set, while the platform is improved to the level of 
performance. On the other hand, as the clinic study will be elaborated in 
medium-sized hospitals also favors the situation described. 
This way, we can conclude that the solution comply with the proposal 
requirements.  
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Figure 70 – Performance results of the HemoSpec Platform 
 
  
0
1
2
3
4
5
6
7
10 100 500 1000 5000
T
im
e 
/s
Patient number
Load test
Actions associated with patient analysis Patients
  99 
Chapter 6 
 Conclusion 
The main goal of this thesis was the study, design and development of a 
solution that covers the limitations and problems found in the current 
treatment process of sepsis disease. Thus, this work started with a careful 
requirements analysis in order to understand which features the solution 
should support. After getting the requirements of the solution we came up 
with an architecture for the desired solution. As a result we presented 
HemoSpec platform, a web-based platform that supports an automated 
diagnostic and monitoring of sepsis disease. 
The user interface was carefully developed targeting simplicity and 
intuitive interactions, through direct visualization of the information 
associated with the patients, specifically the current consults status. 
Additionally, it provides a rich set of features to support the complete 
workflow of diagnostic and monitoring of sepsis in real - time, such as the 
control of a device associated with an organization, the control of the analysis 
process and the control of organizational data. 
The developed solution intends, also, to reduce the time of diagnostic and 
monitoring of sepsis, thusly improving the rate of success of the treatment 
and reducing the mortality rate. For this aim, our solution needs to control 
just one unique analysis executed by the HemoSpec device, which ensures 
liability and data exchange security. Simultaneously, the proposed workflow 
speeds up the execution velocity of the respective analysis. To guarantee a 
correct processing, it was necessary to implement a communication protocol 
with the objective of ensuring that user actions and the data exchange are 
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instantaneous during the workflow without any occurring problems and 
respecting the proposed requirements. 
In the way to evaluate the usability and performance of the HemoSpec 
platform, we realized specific tests with the objective of obtaining conclusive 
results. After the several tests were realized, the platform presented 
convincing results in terms of usability, liability and performance, exceeding 
expectation proposals. We can affirm that the developed solution meets the 
solution's goals. 
 
6.1. Future Work 
Though HemoSpec platform provides a rich set of features that makes it 
an innovative and flexible solution with many advantages for the sepsis 
treatment, we are aware that many features can be integrated in the platform 
to further improve it, such as:  
 Improve the performance of the platform, in the way to support 
large increases in the number of patients and maintaining good 
performance levels; 
 Integrate statistics section, which shows data about the current 
situation of the sepsis disease; 
 Import additional and relevant documents to the study 
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Appendix A 
 User Interface Evaluation 
This appendix contains all the documentation used to support the user 
interface usability evaluation, and the results obtained after a careful 
analysis. 
A.1 Usability Test 
 Documents 
Documents used in the usability tests. 
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 Questionnaire guide 
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Introduction and goals 
The purpose of this round of testing involves feedback from the user to 
the proposed structure for the Master thesis in HemoSpec Platform, 
identifying serious problems during a development phase. 
Specific questions to be answered: 
 The navigation conventions make sense? 
 The navigation structure is easy and intuitive? 
 The desired information is easy to find? 
 User knows, every time, where and what he can do? 
 
User characteristics 
 Age group representative: participants above 20 years; 
 It is not fundamental representative genus division; 
 Participants can in no way be connected to the development of the 
platform; 
 Participants should be agile enough regarding computer usage.  
 
Methodology 
We will submit to each participant how the test will be executed telling 
them to speak out loud about everything they are seeing, doing and thinking 
during the session. If applicable, each participant will be called to fulfill a 
confidential form provided by us. Participants will then have a number of 
tasks to perform. Each session will have an approximated duration of twenty 
minutes. 
Once all tasks done, it will be given to the user the possibility of placing 
questions. At last, it will be request each participant to fulfill a small inquiry. 
The test is presented in next page. 
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Test 
 Welcome 
 Presentation of the test 
 Task lists: 
 
o Task 1 
 Login in the platform, as a technician. After, search 
for the patient Jacques Bolton and click in the assign 
button; 
o Task 2 
 To continue the workflow, start the patient’s analysis; 
o Task 3 
 After the microfluidic separation module finishes the 
respective analysis, type some notes about these 
results in the module device page;  
o Task 4 
 Go to device page, stop and start the fluorescence 
module which has triggered an error; 
o Task 5 
 Go to patient page and verify if all data is ok; 
o Task 6 
 Verify the patient’s consult’s details and validate 
results; 
o Task 7 
 Logout from the platform and after login in the 
platform, as physician; 
o Task 8 
 Verify the current information and access to the 
consult’s details of the patient’s Jacques Bolton; 
o Task 9 
 Check for comments associated with the microfluidic 
separation module results; 
o Task 10 
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 Check for technician answers in the technician 
validation section; 
o Task 11 
 Submit a treatment guide for Jacques Bolton medical 
issue; 
o Task 12 
 Add a new patient with the health number 60149 or 
higher; 
o Task 13 
 Request a study to the added patient; 
o Task 14 
 Logout from the platform and after login in the 
platform, as technician. Click in the assign button 
associated with the new patient; 
o Task 15 
 Start the patient analysis; 
o Task 16 
 Click in reanalysis button; 
o Task 17 
 Validate results; 
o Task 18 
 Logout from the platform and after login in the 
platform, as physician. Submit a treatment guide for 
the last patient analysis; 
o Task 19 
 Go to device page; search the history table for the 
patient that you added; 
o Task 20 
 Logout from the platform and after login in the 
platform, as administrator. 
o Task 21 
 Access to the manage page; 
o Task 22 
 Choose the Jena organization; 
o Task 23 
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 Access to patient section and edit the name of the 
patient that you added; 
o Task 24 
 Change the organization name; 
o Task 25 
 Logout from the platform and login in the platform, as 
technician or physician; 
o Task 26 
 Go to device page; search in the history table for the 
patient added; 
o Task 27 
 Search again by the new name; 
o Task 28 
 Logout from the web platform. 
 
 After test inquiry. 
 
Tester guide 
Here, we present a set of relevant patterns that the tester will try to follow 
during the writing of reports: 
 Does the user understand well the objective for each task and 
respective interactions? 
 Did he/she find easily the interface components that fit the 
purpose? Which was the location of the components he/she 
thought? 
 How did he interpret each task?  This means what he thinks he has 
to do, where to click, what action is under the button event and 
what is going to happen in consequence. 
 Did the user need help to perform some task? What was the task 
and why did he/she get stuck? 
 Did the user gain easily sensibility and experience using the 
platform? 
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During the writing of the reports, the tester will cover the maximum 
possible points discussed above without disturbing the user nor 
interfering with the test. 
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Report 
Note: Use this space for additional notes or comments 
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User name:  Evaluation table of the tester 
Task Number of clicks Did the user finish 
the task? 
Did the user make mistakes? Got lost? Call for help? How easily observed 
1 – Not easy 
5 – Extremely easy 
1  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
2  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
3  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
4  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
5  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
6  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
7  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
8  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
9  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
10  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
11  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
12  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
13  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
14  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
15  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
16  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
17  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
18  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
19  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
20  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
21  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
22  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
23  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
24  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
25  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
26  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
27  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
28  Yes: ___    No: ___ No: ___    Few: ___    Many: ___ No: ___  Little: ___  Very: ___ Yes: ___    No ___    Which? 1 2 3 4 5 
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Script of usability testing 
Introduction and goals 
Hello, I am Tiago Lourenço and you will work with my project in this 
section. I’d like to start presenting you briefly what we are going to do and 
what I am trying to obtain. 
So, today I will evaluate the structure of the HemoSpec Platform. Your 
experience will help me assuring that this platform is simpler, user-friendly 
and intuitive. During the session, there will be a tester controlling you and 
observing you while you explore the platform. 
Please, remember I don’t intend somewhat to evaluate you. I am just 
trying to understand how people use the platform. Do your best but don’t 
worry with the results. Any question or problem along the essay you must 
tell, in order to develop a better product. 
This way you will have a list of tasks that must be done in a current and 
beta version of the platform, therefore pay attention for every detail. 
I ask you that, at each moment and per task, to speak out loud about 
everything you see and think, what you are looking for, what you are doing 
and what you expect to obtain. You will be under supervision of a tester who 
will note down main aspects of your behavior using the system, yours errors, 
tries and comments you make. The more information you provide the better. 
Now, the tester will explain in general how works the platform. 
After the explanation, if do you have any doubt ask? If not, lets begin. 
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Tasks list 
To access in the platform use:  
o Physician email: cjmlourenco@gmail.com 
o Technician email: loirovila@gmail.com 
o Administrator email: tiago.vf.lourenco@gmail.com 
All users have the same password: Tiago9 
 Tasks list: 
o Task 1 
 Login in the platform, as a technician. After, search for 
the patient Jacques Bolton and click in the assign 
button; 
o Task 2 
 To continue the workflow, start the patient’s analysis; 
o Task 3 
 After the microfluidic separation module finishes the 
respective analysis, type some notes about these 
results in the module device page;  
o Task 4 
 Go to device page, stop and start the fluorescence 
module which has triggered an error; 
o Task 5 
 Go to patient page and verify if all data is ok; 
o Task 6 
 Verify the patient’s consult’s details and validate 
results; 
o Task 7 
 Logout from the platform and after login in the 
platform, as physician; 
o Task 8 
 Verify the current information and access to the 
consult’s details of the patient’s Jacques Bolton; 
o Task 9 
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 Check for comments associated with the microfluidic 
separation module results; 
o Task 10 
 Check for technician answers in the technician 
validation section; 
o Task 11 
 Submit a treatment guide for Jacques Bolton medical 
issue; 
o Task 12 
 Add a new patient with the health number 60149 or 
higher; 
o Task 13 
 Request a study to the added patient; 
o Task 14 
 Logout from the platform and after login in the 
platform, as technician. Click in the assign button 
associated with the new patient; 
o Task 15 
 Start the patient analysis; 
o Task 16 
 Click in reanalysis button; 
o Task 17 
 Validate results; 
o Task 18 
 Logout from the platform and after login in the 
platform, as physician. Submit a treatment guide for 
the last patient analysis; 
o Task 19 
 Go to device page; search the history table for the 
patient that you added; 
o Task 20 
 Logout from the platform and after login in the 
platform, as administrator. 
o Task 21 
 Access to the manage page; 
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o Task 22 
 Choose the Jena organization; 
o Task 23 
 Access to patient section and edit the name of the 
patient that you added; 
o Task 24 
 Change the organization name; 
o Task 25 
 Logout from the platform and login in the platform, as 
technician or physician; 
o Task 26 
 Go to device page; search in the history table for the 
patient added; 
o Task 27 
 Search again by the new name; 
o Task 28 
 Logout from the web platform. 
 
After test inquiry 
Please help me fulfilling this inquiry based on your experience during the 
test. 
How do you rate your tasks during the 
test? 
Hard 1 2 3 4 5 Easy 
How do you rate the main design of 
the platform? 
Confused 1 2 3 4 5 Evident 
Was the navigation through the 
platform intuitive? 
Rarely 1 2 3 4 5 Always 
Is the platform hard to understand? Hard 1 2 3 4 5 Easy 
How do you rate it globally? Bad 1 2 3 4 5 Good 
Would do you recommend it to 
someone? 
Never 1 2 3 4 5 Sure 
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